samedan logo
 
 
spacer
home > ebr > summer 2003 > england - europe's low risk biotech location
PUBLICATIONS
European BioPharmaceutical Review

England - Europe's Low Risk Biotech Location

Scientists worldwide are celebrating the 50th anniversary of the deciphering of the structure of DNA. But in Cambridge there is special cause for celebration, for Crick and Watson made this ground-breaking discovery at the Cavendish Laboratory in Cambridge. Moreover, Sir John Sulston, winner of last year's Nobel Prize, is also a Cambridge scientist.

Read full article >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Jeanette Walker, Business Development Director at ERBI

Jeanette Walker is a graduate in Law and French from the University of Kent. She subsequently gained a Diploma in European Export Marketing from the University of Louvain in Belgium. She has worked in a variety of international business development roles, most recently as Head of New Business for Invest East of England, the regional inward investment agency.

In her current role at ERBI Jeanette also runs a wide range of programmes and events aimed at supporting and growing the biotech cluster in the East of England.

spacer
Jeanette Walker
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

Paediatric Clinical Trials

19-20 January 2009, Copthorne Tara Hotel, London, UK


More info >>

 
News and Press Releases

Azopharma Product Development Group, Inc

HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today the addition of innovative state-of-the-art equipment at its formulation and manufacturing division, ApiCross Drug Delivery Technologies in Hollywood, Florida. The most recent acquisition is the MG Futura Capsule Filler which delivers the latest in capsule filling technology. The company has also added a Bausch & Strobel Aseptic Filling Isolator, equipment that is ground-breaking in the powder filling process. These additions support our previously implemented XcelodoseTM powder micro-dosing system. With these technologies, Azopharma is able to provide its clients with all forms of the capsule filling process. The new equipment is part of Azopharma’s recent manufacturing expansion which includes 17 new manufacturing suites for GMP, cytotoxic and aseptic products...
More info >>

 

©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement